Abiopharma

Satellos Receives FDA Fast Track Designation for SAT-3247 for the Treatment of Duchenne Muscular Dystrophy

ADMA INVESTOR NOTICE: ADMA Biologics, Inc. (ADMA) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Sharon AI Announces Closing of US$1.6 Billion Strategic Financing

VENU Joins Russell 3000 and Russell 2000 Indexes

OTC Markets Group Welcomes Surge Energy Inc. to OTCQX

NetraMark Signs New NetraAI Clinical Trial Analysis Agreement with Late-Stage Biopharmaceutical Company

SES AI Announces Inclusion in Russell 3000®Index

Dianthus Therapeutics Announces Initiation of Phase 3 Emerge Trial of Claseprubart in Generalized Myasthenia Gravis

Bitdeer Technologies Group Signs Colocation Lease Agreement for Tydal, Norway AI Data Center Site

NovaBridge Biosciences Appoints Dr. Srishti Gupta as Chief Executive Officer